Pathophysiology and Management Strategies for Uncomplicated Hypertension


  • Annisa Salshabilla Universitas Lampung
  • Citra Yulianda Pardilawati Medical Faculty, Universitas Lampung
  • Putu Ristyaning Ayu Sangging
  • Rasmi Zakiah Oktarlina



Hypertension, Management, patophysiology


Hypertension is called the "silent killer" because there are no specific symptoms for sufferers and it is the main cause of death throughout the world. Hypertension or high blood pressure is a condition where systolic blood pressure increases ≥ 140 mmHg and diastolic blood pressure ≥ 90 mmHg. According to WHO (World Health Organization), an estimated 1.28 billion adults aged 30-79 years suffer from hypertension worldwide. Riskesdas data for 2018 states that the prevalence of hypertension in Indonesia is 658,201. The pathophysiology of hypertension occurs through the process of forming angiotensin I into angiotensin II by angiotensin I converting enzyme (ACE). Management of hypertension includes non-pharmacological management and pharmacological management. Some non-pharmacological management measures include weight loss, implementing Dietary Approaches to Stop Hypertension (DASH), adopting a low salt diet, consuming potassium supplements, increasing physical activity, and reducing alcohol consumption. Recommended pharmacological therapy in hypertensive patients such as ACEi or ARB with CCB or thiazide/thiazide-like diuretics.

Author Biographies

Annisa Salshabilla, Universitas Lampung



Citra Yulianda Pardilawati, Medical Faculty, Universitas Lampung



Putu Ristyaning Ayu Sangging



Rasmi Zakiah Oktarlina




WHO. Hypertension [Online]. 2023 [Diakses pada 30 Januari 2024]. Tersedia dari: news-room/fact sheets/detail/ hypertension

Nuraini B. Risk Factors of Hypertension. J Major. 2015;4(5):10–9.

Dipiro JT, Yee GC, Posey LM, Haines ST, Nolin TD, Posey LM, et al. Pharmacotherapy Hanbook Ed 11Th. DiPiri JT, Yee G., editors. 2020.

Bell K, Twiggs J, Olin BR, Date IR. Hypertension: the silent killer: updated JNC-8 guideline recommendations. Alabama pharmacy association. 2015 Jun 1;334:4222.

Kemenkes RI. Laporan Nasional RISKESDAS. Lembaga Penerbit Balitbangkes. Jakarta; 2018. hal 156.

Wells BG, DiPiro JT, Schwinghammer TL, DiPiro CY. Pharmacotherapy Handbook. Ninth Edit. Vol. 44, Laser Focus World. McGraw-Hill Education; 2015. 87–101 p.

Kadir A. Hubungan Patofisiologi Hipertensi dan Hipertensi Renal. J Ilm Kedokt Wijaya Kusuma. 2018;5(1):15–25.

Chobanian A v. JNC 7 express: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. U.S. Department of Health and Human Service. New York; 2003.

Sylvestris A. Hipertensi Dan Retinopati Hipertensi. Saintika Med. 2014;10(1):1.

Tika TT. PENGARUH PEMBERIAN DAUN SALAM (Syzygium polyanthum) PADA PENYAKIT HIPERTENSI : SEBUAH STUDI LITERATUR. J Med [Internet]. 2021;03(01):1260–5. Available from:

Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Himmelfarb CD, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults a report of the American College of Cardiology/American Heart Association Task Force on Clinical pr. Vol. 71, Hypertension. 2018: 13–115 p.

Mancia(Chairperson) G, Kreutz(Co-Chair) R, Brunström M, Burnier M, Grassi G, Januszewicz A, et al. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension Endorsed by the European Renal Association (ERA) and the International Society of Hypertensi. Vol. Publish Ah, Journal of Hypertension. 2023.

Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34(28):2159–219.

Williams B, Mancia G, Spiering W, Rosei EA, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Vol. 77, Kardiologia Polska. 2018: 71–159 p.

Katzung BG, Masters SB, Trevor AJ. Farmakologi Dasar & Klinik Edisi 12. Vol. 53, Journal of Chemical Information and Modeling. 2013. 1689–1699 p.



How to Cite

Salshabilla, A. ., Pardilawati, C. Y., Sangging, P. R. A., & Oktarlina, R. Z. (2024). Pathophysiology and Management Strategies for Uncomplicated Hypertension. Medical Profession Journal of Lampung, 14(4), 640-646.




Most read articles by the same author(s)

1 2 3 4 5 > >>